Skip to main content


Figure 2 | Arthritis Research & Therapy

Figure 2

From: Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis

Figure 2

Effect of sPLA2I pre-treatment on histopathology of joint. At the completion of the 14-day pre-treatment study all arthritic knee joints were removed and prepared for histological evaluation. Knee sections were scored (0 to 8) for the degree of cellular infiltration, synovial hyperplasia, cartilage damage and bone erosions. Only rats orally treated with the sPLA2I at 5 mg/kg/day showed a significant reduction in histopathology scores. Each data point represents a specific score with the median shown. ** indicates significant difference (P < 0.01) between arthritis controls and treatment group using the Mann-Whitney U test.

Back to article page